Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Dyne Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | ||||||||||||||||
Equity | Common stock, par value $0.0001 per share | Other(2) | 5,115,931(3) | $13.80(2) | $70,599,847.80 | 0.0001531 | $10,808.84 | ||||||||||||||||
Total Offering Amounts |
| $70,599,847.80 |
| $10,808.84 | |||||||||||||||||||
Total Fee Offsets |
|
|
| - | |||||||||||||||||||
Net Fee Due |
|
|
| $10,808.84 | |||||||||||||||||||
(1) In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low sales price of the registrant’s common stock on the Nasdaq Global Select Market on February 25, 2025.
(3) Consists of 5,115,931 additional shares issuable under the 2020 Stock Incentive Plan.
